FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...